NovoCure (NVCR) Inventory (2014 - 2026)

NovoCure (NVCR) has reported Inventory for 13 consecutive years, with $42.2 million the latest figure, recorded in Q2 2026.

• Quarterly Inventory rose 5.01% year-over-year to $42.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $42.2 million (up 5.01% YoY) and the FY2025 annual result came in at $41.1 million, up 17.17% from the prior year.
• Inventory eased to $42.2 million in Q2 2026 per NVCR's latest filing, from $43.5 million in the prior quarter.
• Over the last five years, Inventory for NVCR reached as high as $43.5 million in Q1 2026 and fell as low as $26.8 million in Q3 2022.
• A 5-year average of $36.5 million and a median of $38.6 million in 2023 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory jumped 37.38% — and 2024, when it slipped 8.04%.
• Year by year, Inventory stood at $29.4 million in 2022, then climbed by 29.87% to $38.2 million in 2023, then fell by 8.04% to $35.1 million in 2024, then rose by 17.17% to $41.1 million in 2025, then advanced by 2.71% to $42.2 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $42.2 million, $43.5 million, and $41.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.